INTRODUCTION
It is now generally felt that oestrogen-progestin combinations alter the uterine physiology in a manner which is not consistent with normal nidation. 
DISCUSSION
It will be noted that with slight variations the sequence of changes in the endo¬ metrial pattern produced with 2, 1 and 0-5 mg of ethynodiol diacetate plus mestranol is similar, i.e. there is a hastening of the glandular development in the early days of treatment followed by regression of these elements along with pseudodecidualization of the stroma during the latter part of the cycle (Roland, 1958;  Marqueo, Perez Vega, Goldzeiher, Martinez-Manautou & Rudel, 1963; Durkin, Lin & Kim, 1965) . In the case of Sc. 11800 0-1 mg plus mestranol, the endometrium continued to show proliferative changes half way through the cycle and secretory activity in the second half of the cycle appeared similar to changes occurring in a normal cycle. The stroma showed variable amounts of oedema and the pseudodecidual reaction was never marked.
Thus, it may be suggested that this low dosage progestin combination is less likely to produce the atrophie endometria and scanty menses which have been commented upon in cases of prolonged use of these drugs as oral contra¬ ceptives. The cost of the drug ought to be reduced because of the low progestin dosage. However, its comparative efficacy as an effective contraceptive needs to be evaluated on a larger scale.
We must be cautious in generalizing from the limited number of cases studied in our series, but nevertheless the effects were quite constant in the samples available.
